Page 100 - Syndipharma

Product List IRANIAN PHARMACEUTICAL COMPANIES DIRECTORY

No Type Brand Name Product Dosage Strength Indication Status
Form
1 Immunosuppressant AFINITOR TAB EVEROLIMUS TABLET TABLET 5 mg ANTINEOPLASTIC In the
5MG ORAL 5 mg ORAL AGENTS Market
2 NSAID CATAFLAM SCT DICLOFENAC POTAS- TABLET 50 mg ANTIINFLAMMATORY In the
50MG SIUM TABLET ORAL ORAL AND ANTIRHEUMATIC Market
50 mg PRODUCTS
3 Organ transplanta- CERTICAN TAB EVEROLIMUS TABLET TABLET 0.25 mg IMMUNOSUPPRES- In the
tion 0.75MG ORAL 0.25 mg ORAL SANTS Market
4 Organ transplanta- CERTICAN TAB EVEROLIMUS TABLET TABLET 0.75 mg IMMUNOSUPPRES- In the
tion 0.25MG ORAL 0.75 mg ORAL SANTS Market
5 Cardiovascular DIOVAN FCT VALSARTAN TABLET TABLET 160 mg ANGIOTENSIN II AN- In the
160MG ORAL 160 mg ORAL TAGONISTS, COMBINA- Market
TIONS (Hypertension)
6 Cardiovascular DIOVAN FCT VALSARTAN TABLET TABLET 80 mg ANGIOTENSIN II AN- In the
80MG ORAL 80 mg ORAL TAGONISTS, COMBINA- Market
TIONS (Hypertension)
7 CNS EXELON HGC RIVASTIGMINE CAP- CAPSULE 1.5 mg ANTI-DEMENTIA In the
1.5MG SULE ORAL 1.5 mg ORAL DRUGS Market
8 CNS EXELON HGC RIVASTIGMINE CAP- CAPSULE 3 mg ANTI-DEMENTIA In the
3MG SULE ORAL 3 mg ORAL DRUGS Market
9 CNS EXELON HGC RIVASTIGMINE CAP- CAPSULE 4.5 mg ANTI-DEMENTIA In the
4.5MG SULE ORAL 4.5 mg ORAL DRUGS Market
10 CNS EXELON HGC RIVASTIGMINE CAP- CAPSULE 6 mg ANTI-DEMENTIA In the
6MG SULE ORAL 6 mg ORAL DRUGS Market
11 Cardiovascular EXFORGE FCT AMLODIPINE/VAL- TABLET 10 ANGIOTENSIN II AN- In the
160/10MG SARTAN TABLET ORAL mg/160 TAGONISTS, COMBINA- Market
ORAL 10 mg/160 mg mg TIONS (Hypertension)
12 Cardiovascular EXFORGE FCT AMLODIPINE/ATOR- TABLET L 160 ANGIOTENSIN II AN- In the
160/5MG VASTATIN TABLET ORAL mg/5 mg TAGONISTS, COMBINA- Market
ORAL 160 mg/5 mg TIONS (Hypertension)
13 Cardiovascular EXFORGE FCT AMLODIPIN/VALSAR- TABLET 5 mg/80 ANGIOTENSIN II AN- In the
80/5MG TAN TABLET ORAL 5 ORAL mg TAGONISTS, COMBINA- Market
mg/80 mg TIONS (Hypertension)
14 Oncology EXJADE TAB DEFERASIROX TAB- FOR SUS- 125 mg Iron chelating agents In the
125MG LET, FOR SUSPEN- PENSION (Thalacemia) Market
SION ORAL 125 mg ORAL
15 Oncology EXJADE TAB DEFERASIROX TAB- FOR SUS- 250 mg Iron chelating agents In the
250MG LET, FOR SUSPEN- PENSION (Thalacemia) Market
SION ORAL 250 mg ORAL

99
you can find the rest of the product list on page 311